20277 results for «»
20277 results
Learning from the Masters - Key learnings from 20 years of transcatheter edge-to-edge repair
15 May 2024 – From EuroPCR 2024
Maurizio Taramasso interviews Ottavio Alfieri, a pioneering figure in valve surgery and a key contributor to the development of transcatheter edge-to-edge repair, honored with the Ethica Award at the 2024 edition of #europcr. Ottavio Alfieri discusses his journey to becoming a cardiac surgeon, the genesis of...

First report of an IDE pivotal study of a dedicated splitting device during TAVR
15 May 2024 – From EuroPCR 2024
Watch this interview in which Christopher Cook hosts Martin Leon to discuss pivotal study data on the ShortCut dedicated leaflet splitting device. They revisit the unmet clinical need for leaflet splitting during TAVR: transcatheter valve failures, noting that transcatheter valve failures could surpass surgical bioprosthetic valve failures...

What are the key considerations for first-time TAVI in a patient with long life expectancy?
15 May 2024 – From EuroPCR 2024
Interviewed by Dan Blackman, Philip Maccarthy discusses the rising trend of TAVI in younger patients and emphasizes optimizing first-TAVI procedure outcomes for long-term durability. He highlights considerations such as haemodynamics, low gradient, and minimizing paravalvular leak (PVL), as well as the importance of coronary access and...

When and how to treat the side branch in non-left main bifurcations?
16 May 2024 – From EuroPCR 2024
In this video, Jens Flensted Lassen and Thomas Cuisset discuss the importance of the side branch during bifurcation percutaneous coronary intervention (PCI). They emphasize that while there is no perfect solution for all patients, decisions must be tailored to each individual case, often influenced by the patient's...

Restoring vessel physiology drives outcomes - The Bioadaptor experience
16 May 2024 – From EuroPCR 2024
Join this session to delve into the unmet needs concerning drug-eluting stents (DES), including poor long-term clinical outcomes, with up to a 50% MACE rate at 10 years, and a non-plateauing 2-3% annual event rate. Explore how DynamX Bioadaptor technology addresses these challenges by maintaining the...

How will the SMART trial results impact our practice and decision making in TAVI?
16 May 2024 – From EuroPCR 2024
Sabine Bleiziffer and Didier Tchétché discuss the SMART trial with Flavio Ribichini in this #europcr 2024 roundtable. The trial compares the self-expandable supra-annular EVOLUT platform and the balloon-expandable intra-annular SAPIEN platform in patients with small aortic annulus, prevalent in up to 40% of Europeans, mainly women....

EuroPCR 2024: Late-breaking data demonstrate significant clinical advantage of Elixir Medical’s DynamX bioadaptor over standard-of-care drug-eluting stent at two years
14 May 2024

Cracking the calcium code - Novelty and utility of Hertz Contact intravascular lithotripsy
15 May 2024 – From EuroPCR 2024
Follow this session to learn about the novel HC-IVL system, its application for moderate to severe calcified lesions, and procedural tips. The LithiX Hertz Contact IVL addresses unmet needs in coronary artery calcification by offering a simplified workflow with fewer devices and effective treatment for difficult...

Coronary interventions: Highlights of EuroPCR 2024
16 May 2024 – From EuroPCR 2024
In this video, Thomas Cuisset and Davide Capodanno discuss with Dejan Milasinovic key moments in coronary intervention at EuroPCR 2024. They highlight innovations in intravascular imaging education, featuring the Imaging Learning Center and its hands-on workstations, and key studies like DOCTOR-LM, following in the footsteps of OCTOBER or BIFURCATION. Educating...

Amila Premawardhana
Rajiv Das
How to overcome the most clinically relevant challenges in TAVI
14 May 2024 – From EuroPCR 2024
Watch this session to discover insights into patient-prosthesis mismatch and strategies to mitigate risks, delve into the significance of aortic valve commissure for coronary alignment optimization during TAVI, and explore solutions for common TAVI challenges such as peripheral vessel tortuosity and asymmetric valve calcifications in large...

Expanding the heart team - Improved TAVI outcomes through pre-and post-procedure collaboration
16 May 2024 – From EuroPCR 2024
In this session, learn how to advance heart team collaboration through optimized TAVI pre-work-up and refined severe aortic stenosis patient selection, ensuring accurate intervention indications. Gain hands-on insights for effective post-TAVI strategies, explore procedural and valve refinements that simplify post-TAVI PCI, and stay informed on the...

TAVI in TAVI - LIVE case
14 May 2024 – From EuroPCR 2024
A 74-year-old male with a history of cancer, TAVI with Evolut R 34 in 2019, COPD, obesity, and RBBB presents with a symptomatic degenerated valve (regurgitation).
It was decided to implant a Sapien 3 Ultra 26, without pre-dilatation and post-dilatation, using a temporary pacing lead (due to...

Innovation and strategies in TAVI: design, data and directions for clinical practice
15 May 2024 – From EuroPCR 2024
Watch this session to explore considerations for TAVI implantation in small annuli, gain insights into future lifetime management, learn about the benefits of FX technology and clinical evidence beyond small annuli, and witness a live case procedure showcasing the innovation of FX plus. This session is...

Innovations in TMVR and Intrepid trial updates
14 May 2024 – From EuroPCR 2024
Tune in to this session for comprehensive updates on APOLLO and Intrepid TF, along with invaluable lessons gleaned. Discover insights on patient screening for Intrepid TMVR, and delve into clinical case reviews highlighting advancements such as updated 29Fr access. Learn about the safety and efficacy of...

Tough calls during complex PCI
14 May 2024 – From EuroPCR 2024
This joint session with India Live focuses on understanding the reasons for potential failures during complex PCI and strategies to overcome them. It features case presentations and discussions on successfully managing challenging scenarios, including cases where the operator had previously failed, as well as cases where...

Mechanical circulatory support in cardiogenic shock and high-risk PCI
14 May 2024 – From EuroPCR 2024
This session, comprising selected EuroPCR 2024 Abstract submissions, focuses on the use of mechanical circulatory support in cardiogenic shock and high-risk PCI. It includes presentations and discussions on lowering cardiogenic shock mortality through a comprehensive mechanical circulatory support approach, the use of lactate and lactate clearance...

CTO PCI: what a surprise!
14 May 2024 – From EuroPCR 2024
This session, comprising selected EuroPCR 2024 Clinical Case submissions, explores various challenging and unexpected scenarios encountered during CTO PCI procedures. It includes case presentations and discussions on guide wire entrapment and removal, subintimal wiring, revitalizing hope in a low ejection fraction patient, physiologic and hemodynamic considerations...

Stentless PCI
15 May 2024 – From EuroPCR 2024
This session explores various stentless percutaneous coronary intervention (PCI) strategies, including drug-coated balloon (DCB)-only PCI for chronic total occlusions and de-novo coronary lesions, as well as the use of magnesium resorbable scaffolds. Attendees will learn about the rationale, techniques, and outcomes of these "leave nothing behind"...
